Fentanyl use and abuse is rapidly becoming one of the greatest threats to public health in America. The number of overdose deaths per year (70,601 in 2021 per CDC) from this deadly illicitly manufactured fentanyl are staggering and increasing at an alarming rate (25% annually per CDC). One of the most concerning aspects of this situation is fentanyl laced street drugs and substance abusers who unknowingly ingest it (and become addicted to it or overdose from it). This accidental use is resulting in increased drug emergencies and deaths. Clients presenting in your practice may be exposed to illicit fentanyl in other substances they are using, and without proper screening, you and the client may be unaware that a fentanyl addiction is present or developing.
Please join us for a review of the etiology of fentanyl, the need to screen substance disorder clients who may have unsuspectingly ingested it, the role that Narcan plays in saving lives, and your ethical responsibility as a behavioral health care professional to appropriately manage mortal risk when treating clients in the fentanyl landscape.
In addition to the below Objectives, this webinar training includes the following highlights:
1. A Mandatory Disclosure checklist that includes information specific to the fentanyl crisis when treating substance use disorder clients.
2. A discussion of the heightened risks involved in treating substance use disorder clients and how to ethically manage those risks.
3. A discussion of the importance of working with a clinical supervisor/ clinical consultant/ medical consultant in fentanyl or suspected fentanyl SUD cases.
4. How to best approach fentanyl or suspected fentanyl SUD cases inside a treatment team consisting of you (therapist), a medical case manager, a licensed medical professional, and a prescriber.
Cost: $60 – Want to attend this course and any future event or course from our CE library for FREE and unlimited for the cost of $34.99/month for 12 months??!! Check out our Everything Plan here.
This training will provide participants clinical knowledge and tools to:
a). Identify and describe two known facts regarding the etiology of fentanyl.
b). Describe two methods currently used for fentanyl screening.
c). Define what Narcan is, its common uses, and the common qualifications used in best practice to safely administer it.
d). Identify and describe two aspects of mandatory disclosure relevant to SUD treatment for clients addicted to fentanyl or suspected fentanyl.
Clinical Mental Health Professionals such as Counselors, Psychologists, Therapists, Substance Abuse Counselors, and Licensed Clinical Social Workers.
Instructional Level: Intermediate
Instructor(s): Jodi Ann Geis-Crowder, MS, LPC, ACS
Material Author(s): Jodi Ann Geis-Crowder, MS, LPC, ACS
For additional information about this course, the instructors, or the material authors, please contact Content Assistance at firstname.lastname@example.org.
Featured Materials :
Course materials for online asynchronous courses are found in the Lesson module after a course is purchased.